Berzosertib Market In Global
Berzosertib is an inhibitor of ataxia-telangiectasia mutated (ATM) Rad3-related protein kinase (A ... Read More
Wortmannin is a potent, selective, cell-permeable and irreversible inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase)which also potently inhibits polo-like kinase 1.
This report contains market size and forecasts of Wortmannin in global, including the following market information:
Global Wortmannin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Wortmannin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Wortmannin companies in 2021 (%)
The global Wortmannin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wortmannin include Biorbyt, Santa Cruz Biotechnology, Merck, Selleck Chemicals, Adooq Bioscience, BioVision, Abcam, TCI and AbMole, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wortmannin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wortmannin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wortmannin Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Wortmannin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wortmannin Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Wortmannin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wortmannin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wortmannin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Wortmannin revenues share in global market, 2021 (%)
Key companies Wortmannin sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Wortmannin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biorbyt
Santa Cruz Biotechnology
Merck
Selleck Chemicals
Adooq Bioscience
BioVision
Abcam
TCI
AbMole
LifeSpan BioSciences
BOC Sciences
Focus Biomolecules
Bio-Techne
Cayman Chemical
LGC
Enzo Biochem
Thermo Fisher Scientific
StressMarq Biosciences
Aladdin
Berzosertib is an inhibitor of ataxia-telangiectasia mutated (ATM) Rad3-related protein kinase (A ... Read More
Salubrinal is a selective Inhibitor of eIF2α dephosphorylation, inhibiting global protein transl ... Read More
Tolcapone is a reversible inhibitor of catechol-O-methyltransferase.
This report co ... Read More
Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exh ... Read More